Literature DB >> 27320055

Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells.

Hector Rosas-Hernandez1, Elvis Cuevas1, Susan M Lantz1, Kenner C Rice2, Brenda M Gannon3, William E Fantegrossi3, Carmen Gonzalez4, Merle G Paule1, Syed F Ali5.   

Abstract

Designer drugs such as synthetic psychostimulants are indicative of a worldwide problem of drug abuse and addiction. In addition to methamphetamine (METH), these drugs include 3,4-methylenedioxy-methamphetamine (MDMA) and commercial preparations of synthetic cathinones including 3,4-methylenedioxypyrovalerone (MDPV), typically referred to as "bath salts." These psychostimulants exert neurotoxic effects by altering monoamine systems in the brain. Additionally, METH and MDMA adversely affect the integrity of the blood-brain barrier (BBB): there are no current reports on the effects of MDPV on the BBB. The aim of this study was to compare the effects of METH, MDMA and MDPV on bovine brain microvessel endothelial cells (bBMVECs), an accepted in vitro model of the BBB. Confluent bBMVEC monolayers were treated with METH, MDMA and MDPV (0.5mM-2.5mM) for 24h. METH and MDMA increased lactate dehydrogenase release only at the highest concentration (2.5mM), whereas MDPV induced cytotoxicity at all concentrations. MDMA and METH decreased cellular proliferation only at 2.5mM, with similar effects observed after MDPV exposures starting at 1mM. Only MDPV increased reactive oxygen species production at all concentrations tested whereas all 3 drugs increased nitric oxide production. Morphological analysis revealed different patterns of compound-induced cell damage. METH induced vacuole formation at 1mM and disruption of the monolayer at 2.5mM. MDMA induced disruption of the endothelial monolayer from 1mM without vacuolization. On the other hand, MDPV induced monolayer disruption at doses ≥0.5mM without vacuole formation; at 2.5mM, the few remaining cells lacked endothelial morphology. These data suggest that even though these synthetic psychostimulants alter monoaminergic systems, they each induce BBB toxicity by different mechanisms with MDPV being the most toxic. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Blood-brain barrier; Cytotoxicity; MDMA; MDPV; Methamphetamine

Mesh:

Substances:

Year:  2016        PMID: 27320055      PMCID: PMC4983252          DOI: 10.1016/j.neulet.2016.06.029

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  44 in total

Review 1.  A review of the clinical pharmacology of methamphetamine.

Authors:  Christopher C Cruickshank; Kyle R Dyer
Journal:  Addiction       Date:  2009-04-29       Impact factor: 6.526

2.  A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity.

Authors:  T Decker; M L Lohmann-Matthes
Journal:  J Immunol Methods       Date:  1988-11-25       Impact factor: 2.303

Review 3.  Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone.

Authors:  Edward A Ross; Gary M Reisfield; Mary C Watson; Chris W Chronister; Bruce A Goldberger
Journal:  Am J Med       Date:  2012-06-09       Impact factor: 4.965

4.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

5.  Methamphetamine causes sustained depression in cerebral blood flow.

Authors:  Oksana Polesskaya; Jharon Silva; Christine Sanfilippo; Taylor Desrosiers; Anita Sun; Jie Shen; Changyong Feng; Aleksey Polesskiy; Rashid Deane; Berislav Zlokovic; Karl Kasischke; Stephen Dewhurst
Journal:  Brain Res       Date:  2010-12-13       Impact factor: 3.252

6.  Vasoconstriction of porcine left anterior descending coronary artery by ecstasy and cathinone is not an indirect sympathomimetic effect.

Authors:  Kathryn E Baker; Amy A Herbert; Kenneth J Broadley
Journal:  Vascul Pharmacol       Date:  2007-03-19       Impact factor: 5.773

7.  Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: Neuroprotective role in maintaining blood brain barrier integrity.

Authors:  Neil U Parikh; R Aalinkeel; J L Reynolds; B B Nair; D E Sykes; M J Mammen; S A Schwartz; S D Mahajan
Journal:  Brain Res       Date:  2015-07-30       Impact factor: 3.252

8.  Methamphetamine induces the release of endothelin.

Authors:  Jeong-Woo Seo; Susan M Jones; Trisha A Hostetter; Jeffrey J Iliff; G Alexander West
Journal:  J Neurosci Res       Date:  2015-11-16       Impact factor: 4.164

Review 9.  The molecular constituents of the blood-brain barrier.

Authors:  Brian Wai Chow; Chenghua Gu
Journal:  Trends Neurosci       Date:  2015-10       Impact factor: 13.837

10.  Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor.

Authors:  J Ma; J Wan; J Meng; S Banerjee; S Ramakrishnan; S Roy
Journal:  Cell Death Dis       Date:  2014-03-06       Impact factor: 8.469

View more
  11 in total

1.  Monoaminergic toxicity induced by cathinone phthalimide: An in vitro study.

Authors:  Susan M Lantz; Hector Rosas-Hernandez; Elvis Cuevas; Bonnie Robinson; Kenner C Rice; William E Fantegrossi; Syed Z Imam; Merle G Paule; Syed F Ali
Journal:  Neurosci Lett       Date:  2017-07-03       Impact factor: 3.046

2.  Characterization of Biaxial Stretch as an In Vitro Model of Traumatic Brain Injury to the Blood-Brain Barrier.

Authors:  Hector Rosas-Hernandez; Elvis Cuevas; Claudia Escudero-Lourdes; Susan M Lantz; Nancy P Gomez-Crisostomo; Nasya M Sturdivant; Kartik Balachandran; Syed Z Imam; William Slikker; Merle G Paule; Syed F Ali
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

3.  Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Kaveish Sewalia; Lucas R Watterson; Alyssa Hryciw; Anna Belloc; J Bryce Ortiz; M Foster Olive
Journal:  Neuropharmacology       Date:  2017-11-26       Impact factor: 5.250

Review 4.  Psychoactive Bath Salts and Neurotoxicity Risk.

Authors:  Beril Altun; İsmet Çok
Journal:  Turk J Pharm Sci       Date:  2020-04-24

5.  Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.

Authors:  Teresa Coccini; Sarah Vecchio; Marta Crevani; Uliana De Simone
Journal:  Neurotox Res       Date:  2018-06-22       Impact factor: 3.911

Review 6.  Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?

Authors:  Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2018-10-27       Impact factor: 4.530

Review 7.  DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.

Authors:  Steven J Simmons; Jonna M Leyrer-Jackson; Chicora F Oliver; Callum Hicks; John W Muschamp; Scott M Rawls; M Foster Olive
Journal:  ACS Chem Neurosci       Date:  2018-05-11       Impact factor: 4.418

8.  Endoplasmic Reticulum Stress Mediates Methamphetamine-Induced Blood-Brain Barrier Damage.

Authors:  Xiaojuan Qie; Di Wen; Hongyan Guo; Guanjie Xu; Shuai Liu; Qianchao Shen; Yi Liu; Wenfang Zhang; Bin Cong; Chunling Ma
Journal:  Front Pharmacol       Date:  2017-09-14       Impact factor: 5.810

Review 9.  An updated review on synthetic cathinones.

Authors:  Jorge Soares; Vera Marisa Costa; Maria de Lourdes Bastos; Félix Carvalho; João Paulo Capela
Journal:  Arch Toxicol       Date:  2021-06-08       Impact factor: 5.153

10.  Acute MDPV Binge Paradigm on Mice Emotional Behavior and Glial Signature.

Authors:  Mafalda Campeão; Luciana Fernandes; Inês R Pita; Cristina Lemos; Syed F Ali; Félix Carvalho; Paulo Rodrigues-Santos; Carlos A Fontes-Ribeiro; Edna Soares; Sofia D Viana; Frederico C Pereira
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.